Nov. 18, 2024
In host cell culture-based biopharmaceutical production, the target product can either remain within the cell as an intracellular product or be released into the surrounding culture medium as an extracellular product. View More
Nov. 12, 2024
The biopharmaceutical manufacturing landscape has undergone significant changes over the past decade due to the rapid adoption of polymer-based single-use technologies. Traditionally, pharmaceutical companies relied on stainless steel equipment for the development and production of biotherapeutics. View More 
Nov. 06, 2024
Duoning Biotechnology Group announced a strategic partnership agreement with Branca Bunús Ltd. Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents. View More 
Copyright © Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: 
Message-
